Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biotest AG Increases FY 2013 Guidance


Tuesday, 12 Nov 2013 03:00am EST 

Biotest AG announced that the Managing Board significantly raised the company's forecast for profit before interest and tax (EBIT) in 2013. The Management now expects a sales increase of 10% - 15% and an EBIT increase of 15% - 20%. Until now the EBIT increase had been forecasted with an increase of 10% - 15%. 

Company Quote

75.2
0.2 +0.27%
15 Aug 2014